Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Alt

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Nanoscale Advances|September 14, 2023
Progress in magnetic particle imaging signal and iron quantification methods <i>in vivo</i> - application to long circulating SPIONsJurie Tashkandi, Robert Brkljača, Karen Alt
Journal of the American Society of Nephrology : JASN|December 20, 2024
Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future DirectionsAmir Roointan, Rong Xu, Simon Corrie, et al.
Nanoscale|June 16, 2025
Comparative evaluation of polymer coated <i>versus</i> antibody modified SPIONs for tumor detection using magnetic particle imagingJurie Tashkandi, Robert Brkljača, Marie Zhang, et al.
The Prostate|November 30, 2007
Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID micePhilipp Wolf, Karen Alt, Patrick Bühler, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2019
Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted NanomedicineRania A Hashad, Jaclyn L Lange, Natasha C W Tan, et al.
Journal of the American Heart Association|September 13, 2021
Collagen-Targeted Peptides for Molecular Imaging of Diffuse Cardiac FibrosisMartin Ezeani, Asif Noor, Karen Alt, et al.
The Prostate|November 26, 2009
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancerPhilipp Wolf, Nikolaus Freudenberg, Patrick Bühler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancerPhilipp Wolf, Karen Alt, David Wetterauer, et al.
The Prostate|August 6, 2010
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMAKaren Alt, Stefan Wiehr, Walter Ehrlichmann, et al.
In Vivo (Athens, Greece)|February 2, 2011
In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancerMartin Behe, Karen Alt, Friederike Deininger, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Nanoscale Advances|September 14, 2023
Progress in magnetic particle imaging signal and iron quantification methods <i>in vivo</i> - application to long circulating SPIONsJurie Tashkandi, Robert Brkljača, Karen Alt
Journal of the American Society of Nephrology : JASN|December 20, 2024
Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future DirectionsAmir Roointan, Rong Xu, Simon Corrie, et al.
Nanoscale|June 16, 2025
Comparative evaluation of polymer coated <i>versus</i> antibody modified SPIONs for tumor detection using magnetic particle imagingJurie Tashkandi, Robert Brkljača, Marie Zhang, et al.
The Prostate|November 30, 2007
Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID micePhilipp Wolf, Karen Alt, Patrick Bühler, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2019
Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted NanomedicineRania A Hashad, Jaclyn L Lange, Natasha C W Tan, et al.
Journal of the American Heart Association|September 13, 2021
Collagen-Targeted Peptides for Molecular Imaging of Diffuse Cardiac FibrosisMartin Ezeani, Asif Noor, Karen Alt, et al.
The Prostate|November 26, 2009
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancerPhilipp Wolf, Nikolaus Freudenberg, Patrick Bühler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancerPhilipp Wolf, Karen Alt, David Wetterauer, et al.
The Prostate|August 6, 2010
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMAKaren Alt, Stefan Wiehr, Walter Ehrlichmann, et al.
In Vivo (Athens, Greece)|February 2, 2011
In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancerMartin Behe, Karen Alt, Friederike Deininger, et al.
Pageof 5